This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Travel credit cards come with various features that can enhance your travel experience. Learn essential insights to maximize your benefits.
25,344 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
In quarterly 13F disclosures, billionaire loeb sold shares of major AI players while adding to a smaller AI stock tha...
The (onon) 2026 earnings call offers critical clues about growth drivers, margin reset, and next steps for investors....
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...
Pipelines may not grab headlines, but their steady cash flow powers dividends for investors who plan ahead. Learn how...
Meet Ornith, the open-source coding model built for agents rather than humans. This article breaks down how it works,...
June's session brought a Dow shakeup and telecom headlines that rattled Verizon. Learn what happened, why it matters,...
Choosing between broad healthcare exposure and biotech specificity can shape a portfolio for years. This guide breaks...
Pentair faced a sharp drop as investors weighed leadership changes, lower guidance, and new scrutiny. This in-depth l...
When a trusted bookkeeper holds the keys to a company’s wire transfers, financial risk rises. This guide explains how...
As UCB prepares to reveal Q2 results, investors should focus on revenue mix, pipeline progress, and margin resilience...
Artificial intelligence is reshaping finance, but the question isn’t simply disruption or protection. This article di...